ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC14398-10mg |
|
115344-47-3 |
Siguazodan
|
0 | C14H16N6O | |
GC14396-100mg |
|
943319-70-8 |
Ponatinib (AP24534)
|
0 | C29H27F3N6O | |
GC14396-50mg |
|
943319-70-8 |
Ponatinib (AP24534)
|
0 | C29H27F3N6O | |
GC14396-10mg |
|
943319-70-8 |
Ponatinib (AP24534)
|
0 | C29H27F3N6O | |
GC14395-500ug |
|
87860-39-7 |
Fostriecin sodium salt
|
0 | C19H26O9PNa | |
GC14395-100ug |
|
87860-39-7 |
Fostriecin sodium salt
|
0 | C19H26O9PNa | |
GC14394-100mg |
|
— |
Cy5 amine (non-sulfonated)
|
0 | C38H54Cl2N4O | |
GC14394-50mg |
|
— |
Cy5 amine (non-sulfonated)
|
0 | C38H54Cl2N4O | |
GC14394-25mg |
|
— |
Cy5 amine (non-sulfonated)
|
0 | C38H54Cl2N4O | |
GC14394-5mg |
|
— |
Cy5 amine (non-sulfonated)
|
0 | C38H54Cl2N4O | |
GC14394-1mg |
|
— |
Cy5 amine (non-sulfonated)
|
0 | C38H54Cl2N4O | |
GC14393-1mg |
|
262418-00-8 |
BVD 10
|
0 | C58H92N16O13 | |
GC14392-50mg |
|
181632-25-7 |
SB 242084
|
0 | C21H19ClN4O2 | |
GC14392-10mg |
|
181632-25-7 |
SB 242084
|
0 | C21H19ClN4O2 | |
GC14391-10mM (in 1mL DMSO) |
|
64953-12-4 |
Moxalactam (sodium salt)
|
0 | C20H18N6O9S • 2Na | |
GC14391-1g |
|
64953-12-4 |
Moxalactam (sodium salt)
|
0 | C20H18N6O9S • 2Na | |
GC14391-500mg |
|
64953-12-4 |
Moxalactam (sodium salt)
|
0 | C20H18N6O9S • 2Na | |
GC14391-250mg |
|
64953-12-4 |
Moxalactam (sodium salt)
|
0 | C20H18N6O9S • 2Na | |
GC14390-1g |
|
1101854-58-3 |
JZL184
|
0 | C27H24N2O9 | |
GC14390-500mg |
|
1101854-58-3 |
JZL184
|
0 | C27H24N2O9 | |